However, the activation of SIRT1 failed to correct the abnormal PFC-LTP in APP/PS1 female mice, which casts doubts on the therapeutic potential of targeting SIRT1 to ameliorate memory dysfunction in female AD mice. The gene discussed is APP; the disease is Alzheimer disease.